bpc 157 pubmed A Food and Drug Administration advisory committee voted to add BPC-157 to a drug compounding list — a move that brings the popular peptide one step closer to being legally available to Stable Gastric Pentadecapeptide BPC 157

Q: Can I split a 5mg vial with someone

animal studies suggest it may support healing of gastric ulcers and damaged intestinal lining Preclinical models suggest it may help modulate inflammation, though this has not been established in controlled human trials Known risks and side effects: Because it is sold as an unregulated research chemical rather than a manufactured pharmaceutical, product purity and dosing accuracy cannot be verified, and the FDA has flagged potential impurities and manufacturing-quality concerns FDA's Category 2 determination specifically cited potential immune reactions and hypersensitivity as a safety concern User-reported (non-clinical-trial) effects include injection-site irritation, redness, or swelling, along with occasional headache, nausea, or lightheadedness, based on anecdotal reporting rather than controlled studies No long-term human safety data exists

Once reconstituted, the solution has a limited shelf life

No complications from checkout to delivery